Cargando…
ND-09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR-ABL signaling
Chronic myeloid leukemia (CML) accounts for approximately 15% of new adult leukemia cases. The fusion gene BCR-ABL is an important biological basis and target for CML. In the present study, a novel compound, ND-09, was developed and its inhibitory effect and mechanism of action on CML growth were ev...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144938/ https://www.ncbi.nlm.nih.gov/pubmed/34036393 http://dx.doi.org/10.3892/or.2021.8087 |